Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...
Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...
The MarketWatch News Department was not involved in the creation of this content. AI-driven robotics platform reduces drug formulation development time from years to months SACRAMENTO, Calif., May 19, ...
Patient-centric drug development improves adherence and outcomes by focusing on patient needs and preferences, with regulatory support from bodies like the FDA. Special populations, including ...
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable ...
Type-3 New Drug Applications, focusing on new dosage forms, dominate the 505(b)(2) pathway approvals, with injectable formulations being the largest category. Stability and manufacturing consistency ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vivtex Corporation, a pre-clinical biotechnology company focused on the oral delivery of biologics into systemic blood circulation or localized into GI tissue, ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results